[
  {
    "ts": "2026-01-09T00:51:31+00:00",
    "headline": "Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn",
    "summary": "US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of more than $20bn in...",
    "url": "https://finance.yahoo.com/news/merck-talks-buy-cancer-drugmaker-212750083.html",
    "source": "Financial Times",
    "provider": "yfinance",
    "raw": {
      "id": "c02e1d7d-86f0-3c3d-833e-0f605758d4c5",
      "content": {
        "id": "c02e1d7d-86f0-3c3d-833e-0f605758d4c5",
        "contentType": "STORY",
        "title": "Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn",
        "description": "",
        "summary": "US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of more than $20bn in...",
        "pubDate": "2026-01-09T00:51:31Z",
        "displayTime": "2026-01-09T00:51:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2023-06/9eb18570-046b-11ee-abfa-6008b1e541ca",
          "originalWidth": 4950,
          "originalHeight": 3144,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rbgNX1ePcKwZLzZG16B47w--~B/aD0zMTQ0O3c9NDk1MDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2023-06/9eb18570-046b-11ee-abfa-6008b1e541ca.cf.webp",
              "width": 4950,
              "height": 3144,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RfLWNvSS9QOylx4dVziNeQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2023-06/9eb18570-046b-11ee-abfa-6008b1e541ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Financial Times",
          "url": "https://www.ft.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-talks-buy-cancer-drugmaker-212750083.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-talks-buy-cancer-drugmaker-212750083.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T00:16:35+00:00",
    "headline": "How Pfizer’s AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment Story",
    "summary": "In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models to Pfizer’s historical R&D data, while a separate multi-year deal with Cartography Biosciences will use its ATLAS and SUMMIT platforms to discover tumor-selective antigens that Pfizer can advance into oncology programs. Together, these alliances highlight Pfizer’s push to use advanced AI and precision oncology tools to improve its internal pipeline productivity at a time...",
    "url": "https://finance.yahoo.com/news/pfizer-ai-precision-oncology-deals-001635744.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "72cb3f01-a83f-3811-9f78-f73bc0636db0",
      "content": {
        "id": "72cb3f01-a83f-3811-9f78-f73bc0636db0",
        "contentType": "STORY",
        "title": "How Pfizer’s AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment Story",
        "description": "",
        "summary": "In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models to Pfizer’s historical R&D data, while a separate multi-year deal with Cartography Biosciences will use its ATLAS and SUMMIT platforms to discover tumor-selective antigens that Pfizer can advance into oncology programs. Together, these alliances highlight Pfizer’s push to use advanced AI and precision oncology tools to improve its internal pipeline productivity at a time...",
        "pubDate": "2026-01-09T00:16:35Z",
        "displayTime": "2026-01-09T00:16:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ai-precision-oncology-deals-001635744.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ai-precision-oncology-deals-001635744.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T12:23:30+00:00",
    "headline": "J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts",
    "summary": "The New Jersey pharma will now offer some of its branded medicines on the US government-created DTC platform, TrumpRx.gov.",
    "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-mfn-drug-pricing-deal-branded-medicines/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "ff0d069b-ad61-3460-9dea-e4701a72a4c0",
      "content": {
        "id": "ff0d069b-ad61-3460-9dea-e4701a72a4c0",
        "contentType": "STORY",
        "title": "J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts",
        "description": "",
        "summary": "The New Jersey pharma will now offer some of its branded medicines on the US government-created DTC platform, TrumpRx.gov.",
        "pubDate": "2026-01-09T12:23:30Z",
        "displayTime": "2026-01-09T12:23:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/ef8ecfc6a5e4a78b276c45c9abb797cc",
          "originalWidth": 1024,
          "originalHeight": 700,
          "caption": "Johnson & Johnson has inked a drug pricing deal with the White House",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VzpCekl2eIipOcsoKH7yMQ--~B/aD03MDA7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/ef8ecfc6a5e4a78b276c45c9abb797cc.cf.webp",
              "width": 1024,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wtqFOx9uBfrdnx.jAIRW4Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/ef8ecfc6a5e4a78b276c45c9abb797cc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-mfn-drug-pricing-deal-branded-medicines/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-cuts-mfn-deal-122330905.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]